-
A Phase 1/2 Open-label Study to Investigate the Safety Efficacy and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults with Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
This study is designed for patients diagnosed with relapsed or refractory B cell precursor acute lymphoblastic leukemia (R/R B-ALL).
This study is a 2-part ...
Phase
Interventional
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test New Study Notification
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
